KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Retained Earnings (2009 - 2026)

Amgen's quarterly Retained Earnings came in at -$190.0 million in Q1 2026, up 99.3% year-on-year from -$95.3 million in Q1 2025, and up 26.36% quarter-over-quarter from -$258.0 million in Q4 2025.

Amgen has reported Retained Earnings for 18 years, with the latest figure at -$190.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Retained Earnings rose 99.3% year-over-year to -$190.0 million; the trailing twelve-month figure through Mar 2026 stood at -$190.0 million (up 99.3% YoY), and the FY2025 full-year result was -$258.0 million, up 99.06% from the prior year.
  • Retained Earnings for Q1 2026 stood at -$190.0 million, up from -$258.0 million in the prior quarter.
  • The five-year high for Retained Earnings was -$126.0 million in Q3 2023, with the low at -$29.6 billion in Q1 2022.
  • Average Retained Earnings over 5 years is -$9.8 billion, with a median of -$544.0 million recorded in 2025.
  • Year-over-year, Retained Earnings plunged 20161.9% in 2024 and soared 99.3% in 2026.
  • Tracing AMGN's Retained Earnings over 5 years: stood at -$231.0 million in 2022, then retreated by 25.11% to -$289.0 million in 2023, then tumbled by 9446.71% to -$27.6 billion in 2024, then surged by 99.06% to -$258.0 million in 2025, then grew by 26.36% to -$190.0 million in 2026.
  • The last three Retained Earnings figures came in at -$190.0 million (Q1 2026), -$258.0 million (Q4 2025), and -$422.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 29.51 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn -14.83 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn -17.87 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 66.72 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn -190.00 Mn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 78.00 Mn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -7.20 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -1.37 Bn
10 Gsk 88.34 Bn 83.66 Bn - 1.76 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -190.00 Mn
Dec 31, 2025 -258.00 Mn
Sep 30, 2025 -422.00 Mn
Jun 30, 2025 -544.00 Mn
Mar 31, 2025 -27.14 Bn
Dec 31, 2024 -27.59 Bn
Sep 30, 2024 -25.53 Bn
Jun 30, 2024 -27.12 Bn
Mar 31, 2024 -190.00 Mn
Dec 31, 2023 -289.00 Mn
Sep 30, 2023 -126.00 Mn
Jun 30, 2023 -25.54 Bn
Mar 31, 2023 -268.00 Mn
Dec 31, 2022 -231.00 Mn
Sep 30, 2022 -652.00 Mn
Jun 30, 2022 -672.00 Mn
Mar 31, 2022 -29.57 Bn
Dec 31, 2021 -796.00 Mn
Sep 30, 2021 -808.00 Mn
Jun 30, 2021 -22.76 Bn
Mar 31, 2021 -833.00 Mn
Dec 31, 2020 -985.00 Mn
Sep 30, 2020 -903.00 Mn
Jun 30, 2020 -20.17 Bn
Mar 31, 2020 -21.38 Bn
Dec 31, 2019 -528.00 Mn
Sep 30, 2019 -20.14 Bn
Jun 30, 2019 -20.05 Bn
Mar 31, 2019 -19.90 Bn
Dec 31, 2018 -17.98 Bn
Sep 30, 2018 -809.00 Mn
Jun 30, 2018 -15.27 Bn
Mar 31, 2018 -14.39 Bn
Dec 31, 2017 -679.00 Mn
Sep 30, 2017 1.77 Bn
Jun 30, 2017 -449.00 Mn
Mar 31, 2017 -362.00 Mn
Dec 31, 2016 -471.00 Mn
Sep 30, 2016 221.00 Mn
Jun 30, 2016 -106.00 Mn
Mar 31, 2016 -268.00 Mn
Dec 31, 2015 -480.00 Mn
Sep 30, 2015 -237.00 Mn
Jun 30, 2015 -68.00 Mn
Mar 31, 2015 137.00 Mn
Dec 31, 2014 -8.00 Mn
Sep 30, 2014 -104.00 Mn
Jun 30, 2014 -123.00 Mn
Mar 31, 2014 -126.00 Mn
Dec 31, 2013 -7.63 Bn
Sep 30, 2013 -7.84 Bn
Jun 30, 2013 -71.00 Mn
Mar 31, 2013 137.00 Mn
Dec 31, 2012 146.00 Mn
Sep 30, 2012 -9.35 Bn
Dec 31, 2011 171.00 Mn
Dec 31, 2010 153.00 Mn
Mar 31, 2010 160.00 Mn
Dec 31, 2009 45.00 Mn
Sep 30, 2009 -4.04 Bn
Jun 30, 2009 63.00 Mn